2021

The New Futures Hackathon for Water Security saw seven teams learn from water security experts from Hunter Water, City of Newcastle, Hunter H2O, and the University of Newcastle before embarking on a 10 hour “hack” to evolve their ideas into a viable, technological solution.

Join us for a full week of Open Access events from Monday the 25th to Friday 29th October.

Associate Professor Sally McFadden was one of a number of pre-startups and startups linked to NSW universities who pitched their solutions to global challenges at the NSW Pearcey Awards University Pitch Competition securing prize money and mentorship.

Help our new students settle in at uni.

The University of Newcastle’s bargaining sessions continued this week with negotiations focussed on how the new agreements can support our university’s goals of equity, sustainability and excellence.

Statement from Vice-Chancellor Professor Alex Zelinsky AO on the release of the NSW Government’s Hydrogen Strategy

The National Museum of Australia (NMA) is full of stored artefacts, each with its own unique story and Dr Julie McIntyre intends to use some of them to write an equally unique Australian history which weaves together narratives of Australia’s environment and its First Peoples.

The University of Newcastle is excited to announce the formation of its inaugural University Equity, Diversity, and Inclusion Committee.

The office of the Pro Vice-Chancellor Research and Innovation is delighted to announce the 2022 Research Advantage Women in Research Fellows. The Selection Review Committee have chosen 13 new Fellows from an extremely strong field across the three colleges.

A significant funding boost will expand learnings from the Name.Narrate.Navigate (NNN) pilot program – a preventive-intervention program developed to address the significant, yet underserviced, issue of youth violence.

Doctor Michael Ruppert has been announced as one of the 2021 Fresh Scientists. This program is run by Science in Public and aims to upskill Early Career Researchers into science communicators.

Encouraging preliminary results from an ongoing phase 1 study have triggered the announcement of phase 2 studies for a first-in-class nasal spray to protect people from respiratory viral diseases such as COVID-19 and influenza.